Synageva BioPharma Corp (NASDAQ:GEVA)

218.11
Delayed Data
As of May 22
 +2.32 / +1.08%
Today’s Change
60.19
Today|||52-Week Range
218.80
+135.06%
Year-to-Date

Today’s Trading

Previous close215.79
Today’s open214.94
Day’s range214.94 - 218.80
Volume862,930
Average volume (3 months)746,944
Market cap$8.1B
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-73.24%
Earnings growth (this year)-25.49%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-51.46%
P/E ratioNM
Price/Sales467.65
Price/Book15.38

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc+5.44+3.15%
XONIntrexon Corp+0.60+1.43%
JUNOJuno Therapeutics In...+0.44+0.95%
CTLTCatalent Inc+0.21+0.67%
Data as of 4:02pm ET, 05/22/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)-$1.79
Annual revenue (last year)$6.5M
Annual profit (last year)-$192.6M
Net profit margin-2,967.47%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Operating Officer
Robert B. Bazemore
Corporate headquarters
Lexington, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers